Pembrolizumab Monotherapy for Previously Untreated Patients With Advanced HCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pembrolizumab monotherapy for previously untreated advanced hepatocellular carcinoma: data from the open-label, phase 2 KEYNOTE-224 trial
Clin. Cancer Res 2022 Apr 14;[EPub Ahead of Print], G Verset, I Borbath, M Karwal, C Verslype, H Van Vlierberghe, A Kardosh, V Zagonel, P Stal, D Sarker, DH Palmer, A Vogel, J Edeline, S Cattan, M Kudo, AL Cheng, S Ogasawara, B Daniele, SL Chan, JJ Knox, SK Qin, AB Siegel, M Chisamore, K Hatogai, A Wang, RS Finn, AX ZhuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.